Valuation: Vaso Corp

Market Cap 5.2Cr 4.64Cr 4.33Cr 3.92Cr 7.39Cr 495.37Cr 7.45Cr 52Cr 20Cr 256.62Cr 20Cr 19Cr 823.09Cr P/E 2024
22.1x
P/E 2025 19.6x
Enterprise Value 1.88Cr 1.67Cr 1.56Cr 1.42Cr 2.67Cr 178.66Cr 2.69Cr 19Cr 7.32Cr 93Cr 7.04Cr 6.89Cr 296.87Cr EV / Sales 2024
-0.03x
EV / Sales 2025 -0.03x
Free-Float
56.11%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 62 16/10/2008
Director of Finance/CFO 65 11/12/2019
Chief Operating Officer 46 01/01/2025
Director TitleAgeSince
Director/Board Member 62 01/06/2007
Director/Board Member 72 10/07/2007
Director/Board Member 81 28/02/2011
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-2.03%+26.34%+37.40% 24TCr
+0.74%+0.74%+10.07%+6.37% 16TCr
-1.30%+3.83%-1.75%+58.60% 15TCr
-1.21%+2.15%-54.61%-10.96% 6.35TCr
-1.30%-2.25%+15.32%+21.95% 4.98TCr
+0.73%+6.60%-15.44%-16.82% 4.93TCr
+0.16%+0.18%+25.60%+57.52% 4.83TCr
+1.95%+6.41%+5.25%+39.66% 4.79TCr
-0.68%-2.49%+29.66%+70.98% 4.25TCr
Average -0.09%+2.26%+4.49%+29.41% 9.47TCr
Weighted average by Cap. -0.10%+1.94%+8.24%+30.80%

Financials

2024 2025
Net sales 8.68Cr 7.75Cr 7.22Cr 6.55Cr 12Cr 826.72Cr 12Cr 86Cr 34Cr 428.27Cr 33Cr 32Cr 1.37TCr 8.91Cr 7.96Cr 7.42Cr 6.73Cr 13Cr 848.91Cr 13Cr 89Cr 35Cr 439.77Cr 33Cr 33Cr 1.41TCr
Net income 10L 8L 8L 7L 13.52L 9.06Cr 13.63L 94.67L 37.13L 4.69Cr 35.71L 34.93L 15Cr 15.69L 14.01L 13.06L 11.84L 22.31L 15Cr 22.48L 1.56Cr 61.26L 7.74Cr 58.92L 57.63L 25Cr
Net Debt -2.39Cr -2.13Cr -1.99Cr -1.8Cr -3.4Cr -227.68Cr -3.42Cr -24Cr -9.33Cr -117.95Cr -8.97Cr -8.78Cr -378.31Cr -3.32Cr -2.97Cr -2.77Cr -2.51Cr -4.73Cr -316.7Cr -4.76Cr -33Cr -13Cr -164.07Cr -12Cr -12Cr -526.22Cr
Logo Vaso Corp
Vaso Corporation principally operates in the healthcare equipment and information technology (IT) industries. The Company's segments include IT, Professional sales service, and Equipment. The IT segment, operating through a wholly owned subsidiary VasoTechnology, Inc., primarily focuses on healthcare IT and managed network technology services. The Professional sales service segment, operating through a wholly owned subsidiary, Vaso Diagnostics, Inc., also known as VasoHealthcare, primarily focuses on the sale of healthcare capital equipment for GE HealthCare Technologies, Inc. into the health provider middle market. The Equipment segment primarily focuses on the design, manufacture, sale and service of proprietary medical devices and software, operating through a wholly owned subsidiary VasoMedical, Inc., which in turn operates through Vasomedical Solutions, Inc. for domestic business and Vasomedical Global Corp. for international business, respectively.
Employees
-